Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Study Shows Otamixaban Substantially Reduced Complications of Invasive Management of Acute Coronary Syndromes
Study Shows Otamixaban Substantially Reduced Complications of Invasive Management of Acute Coronary Syndromes
Study Shows Otamixaban Substantially Reduced Complications of Invasive Management of Acute Coronary Syndromes
Submitted by
admin
on August 30, 2009 - 9:41am
Source:
Yahoo/PR NewsWire
News Tags:
Sanofi
Otamixaban
Headline:
Study Shows Otamixaban Substantially Reduced Complications of Invasive Management of Acute Coronary Syndromes
Do Not Allow Advertisers to Use My Personal information
